Affiliation:
1. University of Shanghai for Science and Technology
2. The Affiliated Hospital of Panzhhua university
Abstract
Abstract
Background
The relationship between systemic immune inflammation index (SII) and the osteoarthritis (OA) has not been well established. This study aimed to investigate the associations between SII and OA risk using data from the National Health and Nutrition Examination Survey (NHANES) 2005–2016.
Methods
A cross-sectional study was conducted using data from participants in NHANES 2005–2016. SII is calculated as platelet count × neutrophil count/lymphocyte count. Multivariable logistic regression models were used to explore the link between SII and osteoporosis, adjusting for potential confounders.
Results
A total of 18,459 participants were included, of which 1130 reported having OA. After adjusting for potential confounders, an inverse association was observed between SII and OA (OR = 1.27; 95% CI = 1.07–1.51, p = 0.006). Moreover, we also identify that SII of 515.56 is the optimal cut-off value, indicating that when the SII value exceeds the cut-off value, the risk increases rapidly.
Conclusions
In this large, nationally representative sample of U.S. adults, higher SII was negatively associated with the risk of OA. Further prospective studies are needed to confirm these findings and elucidate potential underlying mechanisms.
Publisher
Research Square Platform LLC
Reference36 articles.
1. Outlines of the biochemistry of osteoarthritis;Livshits G;Curr Rheumatol Rev,2010
2. Autonomic nervous regulation of cellular processes during subchondral bone remodeling in osteoarthritis;Rösch G;Am J Physiol Cell Physiol,2023
3. Risk of metabolic abnormalities in osteoarthritis: a new perspective to understand its pathological mechanisms;Wei G;Bone Res,2023
4. Inflammation in osteoarthritis: Our view on its presence and involvement in disease development over the years;Bosch MHJ;Osteoarthritis Cartilage,2023
5. Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing;Vlashi R;Rev Endocr Metab Disord,2023